Miguel Marin Vera

Fernandez-Miranda I, Pedrosa L, Llanos M, Franco FF, Gomez S, Martin-Acosta P, Garcia-Arroyo FR, Guma J, Horcajo B, Ballesteros AK, Galvez L, Martinez N, Marin M, Sequero S, Navarro M, Yanguas-Casas N, Calvo V, Rueda-Dominguez A, Provencio M, Sanchez-Beato M. Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study. Clin Cancer Res. 2023 Jan 4;29(1):209-220. doi: 10.1158/1078-0432.CCR-22-1654. PubMed PMID: 36269794; PubMed Central PMCID: PMC9811164.

AÑO: 2023; IF: 11.5

36269794

Rosado-Jimenez L, Mestre-Terkemani Y, Garcia-Aliaga A, Marin-Vera M, Macias-Cerrolaza JA, Sarabia-Meseguer MD, Garcia-Hernandez MR, Zafra-Poves M, Sanchez-Henarejos P, Ayala de la Pena F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Variantes geneticas recurrentes y priorizacion de variantes de significado clinico desconocido asociadas al sindrome de cancer de mama y ovario hereditario en familias de la Region de Murcia. Adv Lab Med. 2023 Jul 10;4(3):288-297. doi: 10.1515/almed-2023-0032. eCollection 2023 Sep. Spanish. PubMed PMID: 38075173; PubMed Central PMCID: PMC10701495.

AÑO: 2023

38075173

Castillo-Guardiola V, Rosado-Jimenez L, Sarabia-Meseguer MD, Marin-Vera M, Macias-Cerrolaza JA, Garcia-Hernandez R, Zafra-Poves M, Sanchez-Henarejos P, Moreno-Locubiche MA, Cuevas-Tortosa E, Arnaldos-Carrillo M, Ayala de la Pena F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance. Eur J Med Genet. 2022 Apr;65(4):104468. doi: 10.1016/j.ejmg.2022.104468. Epub 2022 Mar 1. PubMed PMID: 35245693.

AÑO: 2022; IF: 1.9

35245693

Sánchez-Bermúdez AI, Sarabia-Meseguer MD, García-Aliaga Á, Marín-Vera M, Macías-Cerrolaza JA, Henaréjos PS, Guardiola-Castillo V, Peña FA, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Mutational analysis of RAD51C and RAD51D genes in hereditary breast and ovarian cancer families from Murcia (southeastern Spain). Eur J Med Genet. 2018 Jun;61(6):355-361. doi: 10.1016/j.ejmg.2018.01.015. Epub 2018 Feb 2. PubMed PMID: 29409816.

AÑO: 2018; IF: 2.022

29409816

Castillo-Guardiola V, Sarabia-Meseguer MD, Marín-Vera M, Sánchez-Bermúdez AI, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer. Cancer Genet. 2018 Dec;228-229:1-4. doi: 10.1016/j.cancergen.2018.06.002. Epub 2018 Jun 23. PubMed PMID: 30553462.

AÑO: 2018; IF: 2.183

30553462